Seagen
SGEN
#592
Rank
S$55.06 B
Marketcap
S$291.85
Share price
-0.07%
Change (1 day)
68.15%
Change (1 year)

Earnings for Seagen (SGEN)

Earnings in 2023 (TTM): -S$1.07 Billion

According to Seagen 's latest financial reports the company's current earnings are S$2.30 Billion. In 2022 the company made an earning of -S$0.79 Billion, an increase over its 2021 earnings that were of -S$0.88 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Seagen from 2001 to 2023

Annual earnings

Year Earnings Change
2023 (TTM) -S$1.07 Billion36.34%
2022 -S$0.79 Billion-10.13%
2021 -S$0.88 Billion-214.28%
2020 S$0.76 B-370.63%
2019 -S$0.29 Billion-15.17%
2018 -S$0.34 Billion32.79%
2017 -S$0.25 Billion37.19%
2016 -S$0.19 Billion18%
2015 -S$0.16 Billion56.34%
2014 -S$98.71 Million23.07%
2013 -S$80.21 Million
2011 -S$0.19 Billion111.72%
2010 -S$87.02 Million-19.63%
2009 -S$0.11 Billion-7.55%
2008 -S$0.12 Billion64.95%
2007 -S$71 Million38.4%
2006 -S$51.3 Million25.36%
2005 -S$40.92 Million-14.86%
2004 -S$48.07 Million61.92%
2003 -S$29.69 Million-7.67%
2002 -S$32.15 Million6.76%
2001 -S$30.12 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
S$13.51 B-1,439.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$7.62 B-855.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$2.07 B-305.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$12.24 B-1,313.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.77 B-1,366.34%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-S$78.96 Million-92.17%๐Ÿ‡บ๐Ÿ‡ธ USA
ImmunoGen
IMGN
-S$80.1 Million-92.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.4 Billion-60.91%๐Ÿ‡บ๐Ÿ‡ธ USA